EUROPE INJECTABLE DRUG DELIVERY MARKET 2019-2028

Lifesciences | Pharmaceuticals

EUROPE INJECTABLE DRUG DELIVERY MARKET 2019-2028

Market by Device Type, Route of Administration, End-user, and Country | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton’s research on the Europe injectable drug delivery market depicts that it will grow at a CAGR of 8.22% in terms of revenue during the forecast period 2019-2028.


Report scope can be customized per your requirements. Request For Customization

The countries analyzed in this market include:

           The UK

           France

           Germany

           Russia

           Spain

           Italy

           Rest of Europe countries

The rise in the prevalence of cancer and chronic diseases like CVDs is mainly driving the market for injectable drug delivery systems in the United Kingdom. Statistics from Cancer Research UK indicate that, in 2015, were around 360,000 new cases of cancer were detected in the country’s population. Further, according to the British Heart Foundation, CVDs, are responsible for 160,000 deaths annually in the UK, accounting for 26% of all deaths. It states that, in 2017, there were around 7 million individuals in the country living with cardiovascular diseases.

The alarming rise in the occurrence of these conditions has called for the adoption of devices and treatments to enhance the quality of life of patients. It is necessary to deliver these treatments appropriately and safely to patients for better results. Therefore, there is an increased demand for injectable drug delivery systems in the country, which is aiding the growth of its injectable drug delivery market over the forecast period.

As per the WHO, chronic diseases account for a staggering 93% of the deaths in Germany. It also estimates the prevalence of obesity to increase rapidly over the coming years. Large-molecule IV biologics for treating chronic diseases, delivered in prefilled formats, are being used for frequent drug administration. This is raising the adoption of injectable drug delivery systems in the country, leading to increased market penetration. Thus, the growing prevalence of chronic diseases is helping the German market to flourish over the coming years.

Novo Nordisk A/S provides products for obesity and diabetes acre. It is one of the leaders in the field of hormone replacement therapy, growth hormone therapy, and hemophilia. With its headquarters in Bagsvaerd, Denmark, the company operates across several countries in Europe as well as other regions.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    EUROPE INJECTABLE DRUG DELIVERY MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES MODEL

2.2.1.   THREAT OF NEW ENTRANT

2.2.2.   THREAT OF SUBSTITUTE

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   INTENSITY OF COMPETITIVE RIVALRY

2.3. KEY INSIGHT

2.4. KEY BUYING CRITERIA

2.5. MARKET ATTRACTIVENESS INDEX

2.6. MARKET DRIVERS

2.6.1.   INCREASING GERIATRIC POPULATION

2.6.2.   TECHNOLOGICAL ADVANCEMENT

2.6.3.   GROWING OCCURRENCE OF AUTOIMMUNE DISEASES

2.7. MARKET RESTRAINTS

2.7.1.   HIGH MANUFACTURING COST OF INJECTABLE DRUG DELIVERY SYSTEMS

2.8. MARKET OPPORTUNITIES

2.8.1.   DEVELOPMENT OF BETTER INJECTABLE SYSTEMS

2.8.2.   INCREASE IN HEALTHCARE EXPENDITURE

2.9. MARKET CHALLENGES

2.9.1.   DEVELOPMENTS IN ALTERNATE DRUG DELIVERY SYSTEMS

2.9.2.   STRINGENT REGULATIONS

3.    INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY DEVICE TYPE

3.1. PEN INJECTOR

3.2. AUTO-INJECTOR

3.3. NEEDLE-FREE INJECTOR

3.4. PREFILLED SYRINGE

4.    INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY ROUTE OF ADMINISTRATION

4.1. SUBCUTANEOUS

4.2. INTRAMUSCULAR

4.3. INTRAVENOUS (IV)

4.4. OTHER ROUTE OF ADMINISTRATION

5.    INJECTABLE DRUG DELIVERY MARKET OUTLOOK - BY END-USER

5.1. CLINICS/ PHYSICIAN OFFICES

5.2. AMBULATORY CARE

5.3. HOSPITAL

5.4. HOME-BASED

5.5. OTHER END-USERS

6.    INJECTABLE DRUG DELIVERY MARKET – EUROPE

6.1. COUNTRY ANALYSIS

6.1.1.   UNITED KINGDOM

6.1.2.   GERMANY

6.1.3.   FRANCE

6.1.4.   ITALY

6.1.5.   SPAIN

6.1.6.   RUSSIA

6.1.7.   REST OF EUROPE

7.    COMPANY PROFILES

7.1. BAXTER INTERNATIONAL INC

7.2. BECTON DICKINSON AND COMPANY (BD)

7.3. ELCAM MEDICAL

7.4. ELI LILLY AND COMPANY

7.5. GERRESHEIMER

7.6. INJEX

7.7. NOVARTIS AG

7.8. NOVO NORDISK A/S

7.9. PFIZER INC

7.10.  SANOFI SA

7.11.   SCHOTT AG

7.12.   TERUMO CORPORATION

7.13.   TEVA PHARMACEUTICALS

7.14.  WEST PHARMACEUTICALS

7.15.   YPSOMED HOLDING AG

8.    RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1.   OBJECTIVES OF STUDY

8.1.2.   SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1.   PRIMARY DATA SOURCES

8.2.2.   SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1.   EVALUATION OF PROPOSED MARKET

8.3.2.   IDENTIFICATION OF DATA SOURCES

8.3.3.   ASSESSMENT OF MARKET DETERMINANTS

8.3.4.   DATA COLLECTION

8.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE  1       EUROPE INJECTABLE DRUG DELIVERY MARKET, BY REGION, 2019-2028 ($ MILLION)

TABLE  2       EUROPE INJECTABLE DRUG DELIVERY MARKET, BY DEVICE TYPE, 2019-2028 ($ MILLION)

TABLE  3       DIFFERENT TYPES OF INSULIN PEN INJECTORS

TABLE  4       MARKETED NEEDLE-FREE INJECTORS PRODUCTS

TABLE  5       LYOPHILIZED DRUGS WHICH ARE USED IN PREFILLED SYRINGE

TABLE  6       EUROPE INJECTABLE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 ($ MILLION)

TABLE  7       EUROPE INJECTABLE DRUG DELIVERY MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE  8       EUROPE INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2019-2028 ($ MILLION)      

List of Figures

FIGURE  1     EUROPE INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  2     KEY BUYING IMPACT ANALYSIS

FIGURE  3     EUROPE INJECTABLE DRUG DELIVERY MARKET, BY PEN INJECTOR, 2019-2028 ($ MILLION)

FIGURE  4     EUROPE INJECTABLE DRUG DELIVERY MARKET, BY AUTO-INJECTOR, 2019-2028 ($ MILLION)

FIGURE  5     EUROPE INJECTABLE DRUG DELIVERY MARKET, BY NEEDLE-FREE INJECTOR, 2019-2028 ($ MILLION)

FIGURE  6     EUROPE INJECTABLE DRUG DELIVERY MARKET, BY PREFILLED, 2019-2028 ($ MILLION)

FIGURE  7     EUROPE INJECTABLE DRUG DELIVERY MARKET, BY SUBCUTANEOUS, 2019-2028 ($ MILLION)

FIGURE  8     EUROPE INJECTABLE DRUG DELIVERY MARKET, BY INTRAMUSCULAR, 2019-2028 ($ MILLION)

FIGURE  9     EUROPE INJECTABLE DRUG DELIVERY MARKET, BY INTRAVENOUS, 2019-2028 ($ MILLION)

FIGURE  10  EUROPE INJECTABLE DRUG DELIVERY MARKET, BY OTHER ROUTE OF ADMINISTRATION, 2019-2028 ($ MILLION)

FIGURE  11  EUROPE INJECTABLE DRUG DELIVERY MARKET, BY CLINICS/PHYSICIAN OFFICES, 2019-2028 ($ MILLION)

FIGURE  12  EUROPE INJECTABLE DRUG DELIVERY MARKET, BY AMBULATORY CARE, 2019-2028 ($ MILLION)

FIGURE  13  EUROPE INJECTABLE DRUG DELIVERY MARKET, BY HOSPITAL, 2019-2028 ($ MILLION)

FIGURE  14  EUROPE INJECTABLE DRUG DELIVERY MARKET, BY HOME-BASED, 2019-2028 ($ MILLION)

FIGURE  15  EUROPE INJECTABLE DRUG DELIVERY MARKET, BY OTHER END-USER, 2019-2028 ($ MILLION)

FIGURE  16  UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  17  GERMANY INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  18  FRANCE INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  19  ITALY INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  20  SPAIN INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  21  RUSSIA INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION)

FIGURE  22  REST OF EUROPE INJECTABLE DRUG DELIVERY MARKET 2019-2028 ($ MILLION) 

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;